Ignite Creation Date:
2025-12-24 @ 12:09 PM
Ignite Modification Date:
2026-01-02 @ 2:30 PM
Study NCT ID:
NCT01156961
Status:
WITHDRAWN
Last Update Posted:
2016-11-02
First Post:
2010-07-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2012-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2012-12
Completion Date Type:
ESTIMATED
First Submit Date:
2010-07-02
First Submit QC Date:
None
Study First Post Date:
2010-07-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-01
Last Update Post Date:
2016-11-02
Last Update Post Date Type:
ESTIMATED